ALA-11812-12193
4 vaccinations
3 coded responses
40 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 550 / MN
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Pfizer-BioNTech
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-07-24
- 2021-10-23
-
2021-12-04
Dose 3 — Pfizer-BioNTech
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-27
- 2022-01-01
-
2022-01-08
Survey response — day 35, dose 3MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-15
-
2022-03-05
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sore throat, possibly related to GI issues (GERD and/or ectopic gastric mucosa)MedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-11
-
2022-03-11
Call successfulDoes not wish to fill out VAERS report
-
2022-06-04
Survey response — 6 months, dose 3MedDRA: Cholelithiasis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: GallstoneMedDRA releases: 2024-11 · check-in free text available
-
2022-06-04
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-06-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-28
Dose 4 — Moderna
- 2022-12-06
- 2023-05-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
| 4 | 2022-11-28 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-05 | Successful 2022-03-11 |
Does not wish to fill out VAERS report |
| 2022-06-04 | Successful 2022-06-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — day 35, dose 3
Symptoms: Headache
Release 11 — 3 months, dose 3
Symptoms: Sore throat, possibly related to GI issues (GERD and/or ectopic gastric mucosa)
Release 11 — 6 months, dose 3
Symptoms: Gallstone
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholelithiasis | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release